Amneal Pharmaceuticals, Inc. AMRX Other operating expenses
Other operating expenses at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other operating expenses?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other operating expenses of $6.94M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other operating expenses increased by 35.5% year-over-year, from $5.12M to $6.94M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.